Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 7, 2009, Pages 694-703

  Weinberger, Paul M ^a   Merkley, Mark ^a,b   Lee, Jeffrey R ^a   Adam, Bao Ling ^a   Gourin, Christine G ^a   Podolsky, Robert H ^a   Haffty, Bruce G ^c   Papadavid, Evangelia ^d   Sasaki, Clarence ^d   Psyrri, Amanda ^d   Dynan, William S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DYE; PROTEIN P14; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; AUTOMATION; CELL CYCLE REGULATION; CHEMICAL LABELING; CONTROLLED STUDY; EXTRACTION; FEMALE; FROZEN SECTION; GEL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX; LARYNX; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OROPHARYNX; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MEMBRANE PROTEINS; MICRODISSECTION; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 67651092079     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.78     Document Type: Article

References (39)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49(1):8-31.
2. Sasaki CT, Jassin B. Cancer of the pharynx and larynx. Am J Med. 2001;111(suppl 8A):118S-123S.
3. Sessions RB, Forastiere AA. Cancers of the larynx and hypopharynx. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 5th ed. New York, NY: Lippincott-Raven; 1997.
4. Werner JA, Dunne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck. 2003;25(4):322-332.
5. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(9):951-962. (Pubitemid 28411496)
6. Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Control. 2002;9(5):387-399. (Pubitemid 35204461)
7. Goodwin WJ, Thomas GR, Parker DF, et al. Unequal burden of head and neck cancer in the United States. Head Neck. 2008;30(3):358-371.
8. Répássy G, Forster-Horvath C, Juhasz A, Adany R, Tamassy A, Timar J. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res. 1998;4(1):14-21. (Pubitemid 28257191)
9. Lukits J, Timar J, Juhasz A, Dome B, Paku S, Repassy G. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization. Otolaryngol Head Neck Surg. 2001;125(1):18-22. (Pubitemid 33661085)
10. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res. 1998;18(6B):4793-4800. (Pubitemid 29042062)
11. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res. 2003;63(6):1179-1182. (Pubitemid 36348691)
12. Freier K, Bosch FX, Flechtenmacher C, et al. Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis. Anticancer Res. 2003;23(5A):3971-3977. (Pubitemid 37474351)
13. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 2002;34(2):224-233. (Pubitemid 34578679)
14. Volavsek M, Bracko M, Gale N. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. J Laryngol Otol. 2003;117(4):286-293. (Pubitemid 36469543)
15. Shaw J, Rowlinson R, Nickson J, et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics. 2003;3(7):1181-1195. (Pubitemid 36929540)
16. Sitek B, Luttges J, Marcus K, et al. Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics. 2005;5(10):2665-2679. (Pubitemid 40966494)
17. Wilson KE, Marouga R, Prime JE, et al. Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics. 2005;5(15):3851-3858. (Pubitemid 41502480)
18. Greengauz-Roberts O, Stoppler H, Nomura S, et al. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics. 2005;5(7):1746-1757. (Pubitemid 40686220)
19. Shekouh AR, Thompson CC, Prime W, et al. Application of laser capture micro-dissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics. 2003;3(10):1988-2001. (Pubitemid 37305893)
20. Kondo T, Seike M, Mori Y, Fujii K, Yamada T, Hirohashi S. Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics. 2003;3(9):1758-1766. (Pubitemid 37129823)
21. Haffty BG, Wilson LD, Son YH, et al. Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys. 2005;61(1):119-128.
22. Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Tissue microarray: a new technology for amplification of tissue resources. Cancer J. 2001;7(1):24-31. (Pubitemid 32199100)
23. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. 2001;81(10):1331- 1338. (Pubitemid 32980155)
24. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80(12):1943-1949.
25. Fernebro E, Dictor M, Bendahl PO, Ferno M, Nilbert M. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med. 2002;126(6):702-705. (Pubitemid 34602572)
26. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002;8(11):1323-1327. (Pubitemid 35373567)
27. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47(260):583-621.
28. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin. 1945;1(6):80-83.
29. Spearman C. Demonstration of formulae for true measurement of correlation. Am J Psychol. 1907;18(2):161-169.
30. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116-5121. (Pubitemid 32397092)
31. Karp NA, McCormick PS, Russell MR, Lilley KS. Experimental and statistical considerations to avoid false conclusions in proteomic studies using differential ingel electrophoresis. Mol Cell Proteomics. 2007;6(8):1354-1364.
32. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res. 2007;86(2):104-114.
33. Herrero R, Castellsague X, Pawlita M, et al; IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772- 1783.
34. Psyrri A, Bamias A, Yu Z, et al. Subcellular localization and protein levels of cyclindependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer. Clin Cancer Res. 2005;11(23):8384-8390. (Pubitemid 41746951)
35. Yu Z, Weinberger PM, Haffty BG, et al. Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2005;11(3):1160-1166. (Pubitemid 40175766)
36. Yu Z, Weinberger PM, Provost E, et al. Beta-catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res. 2005;11(7):2471-2477. (Pubitemid 40569442)
37. Harrison PM, Kumar A, Lang N, Snyder M, Gerstein M. A question of size: the eukaryotic proteome and the problems in defining it. Nucleic Acids Res. 2002;30(5):1083-1090. (Pubitemid 34679679)
38. Hatakeyama H, Kondo T, Fujii K, et al. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics. 2006;6(23):6300-6316. (Pubitemid 44935516)
39. Arnouk H, Merkley MA, Podolsky RH, et al. Characterization of molecular markers indicative of cervical cancer progression. Proteomics Clin Appl. In press.